Data Foundry

Medical device recalls 2025

Atellica CH Revised C Reactive Protein — Class II medical device recall Z-1551-2025

Ongoing recall by Siemens Healthcare Diagnostics, Inc., reported 2025-04-16, distributed nationwide. Incorrect software flagging may occur for the assay that may potentially lead to an erroneous result.

Recall numberZ-1551-2025
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmSiemens Healthcare Diagnostics, Inc., Tarrytown, NY, United States
Recall initiated2025-03-11
Classified2025-04-10
Reported by FDA2025-04-16
DistributedNationwide (US)
Countries outside the USAE, AT, AU, BE, BH, BR, BS, CA, CH, CL, CN, CO, CZ, DE, DK, EE, ES, FI, FR, GR, HK, HR, HU, IE, IL, IN, IT, KR, KW, LT, LV, MY, NL, NO, NZ, OM, PK, PL, PT, QA, RO, RS, SE, SG, SI, SK, TW
Reason classespotency, software
UPC / GTIN / UDI-DI00630414610887

Product

Atellica CH Revised C Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223.

Reason for recall

Incorrect software flagging may occur for the assay that may potentially lead to an erroneous result.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1551-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.